Columbia Care Inc. announced today the launch of its proprietary solid-fill cannabis powder capsule for medicinal use throughout the United Kingdom. This is the first solid-fill capsule of its kind available in the UK and the first dose-metered medicinal cannabis product to be manufactured in the UK. The capsules are part of Columbia Care’s trademarked Ceed medicinal product range. The patent-pending, proprietary capsules were first developed and successfully commercialized in the United States by Columbia Care. They incorporate a portfolio of primary and secondary cannabinoids and are available in a number of formulations with various THC and CBD doses. These dosing options enable prescribing physicians to offer proven, cannabis-based medical solutions with a degree of precision previously unavailable in the UK market.
Sean Hocking, Cannabis Law Report, 04/20/2021 04:17:00
Open article: https://cannabislaw.report/columbia-care-launches-first-of-its-kind-medical-cannabis-capsule-in-uk-provides-more-precise-dosing-option-and-longer-lasting-therapeutic-benefits-for-physicians-and-patients/